Orthofix Medical Stock Price and Value Analysis
Should you buy Orthofix Medical stock? (NasdaqGS:OFIX). Let's see how it does in our automated value investing analysis system.
OFIX Free Cash Flow Trend
Hmm, we can't give any reliable projection for Orthofix Medical's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.
None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!
| Advantages | Disadvantages | Neutral |
|---|---|---|
|
|
|
Inside the OFIX Numbers
| OFIX Price (Orthofix Medical stock price per share) |
$6.07 | |
| [?]
|
PE Ratio versus Sector | 1620% higher than other Unknown stocks |
| [?]
|
PE Ratio versus Industry | 865% higher than other Unknown stocks |
| [?]
|
Cash Yield | 14.63% |
| [?]
|
Free Cash Flow Jitter | 209% |
Insider Activity Summary
In the six months to 2026-11-22, no insider bought shares, and 2 insiders sold in 5 trades, about $52 thousand.
The six months before that had 4 buys and 19 sales.
Recent Insider Activity
Open-market buys and sells reported by Orthofix Medical's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-11-02 | Fisher Patrick (President, Global Limb Recon) | Sell | 150 | $9.07 |
| 2026-10-01 | Fisher Patrick (President, Global Limb Recon) | Sell | 150 | $9.44 |
| 2026-09-01 | Fisher Patrick (President, Global Limb Recon) | Sell | 150 | $9.39 |
| 2026-08-18 | Fisher Patrick (President, Global Limb Recon) | Sell | 1,295 | $10.09 |
| 2026-06-18 | McPherron Aviva (Pres, Global Ops & Qual) | Sell | 3,670 | $9.38 |
| 2026-05-07 | HENNEMAN JOHN B III | Buy | 5,000 | $12.26 |
| 2026-04-16 | Cedron Jorge Andres (CLO) | Sell | 3,743 | $12.82 |
| 2026-03-17 | Vitale Lucas (CP&BOO) | Sell | 4,269 | $11.92 |
| 2026-03-10 | CAPPS VICKIE L | Buy | 100 | $12.44 |
| 2026-03-10 | CAPPS VICKIE L | Buy | 2,400 | $12.45 |
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 2,173,386 shares shorted. With 40,435,353 shares available for purchase and an average trading volume over the past 10 trading days of 819,690, it would take at least 2.7 days for all of the short holders to cover their shorts.
Is Orthofix Medical Stock on Sale?
Based on our analysis, we believe that you should not buy Orthofix Medical right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.
Should You Buy OFIX Stock?
Does Orthofix Medical have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.